STOCK TITAN

CARTESIAN GRTH CP II WTS 8-K Filings

REEWF OTC

Every 8-K that CARTESIAN GRTH CP II WTS (REEWF) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow REEWF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full REEWF filings page.

Rhea-AI Summary

Cartesian Growth Corporation II and InoBat AS released an investor presentation describing their proposed business combination. The transaction will later be submitted to Cartesian shareholders after a planned Form F-4 registration statement, which will include a proxy statement/prospectus for voting and for issuing securities to InoBat shareholders.

The presentation outlines InoBat’s energy storage business, including a 2,000 m² battery energy storage system (BESS) production facility in Voderady, Slovakia with capacity to scale up to 5 GWh, and a BESS business with 875 MWh delivered or signed. It highlights partnerships, development of sodium-ion battery technology for BESS and low-voltage automotive uses, and notes that investment decisions should be based on the detailed documents to be filed with the SEC.

Rhea-AI Summary

Cartesian Growth Corporation obtained shareholder approval on July 30, 2026 to amend its Charter and extend the SPAC’s Termination Date for completing its initial business combination from August 5, 2026 to August 5, 2027. This extension became effective upon shareholder approval at the extraordinary general meeting.

On the July 6, 2026 record date, 8,826,094 ordinary shares were entitled to vote, with approximately 89.177% represented at the meeting. The Extension Proposal passed with 7,870,808 votes for, and no votes against or abstentions. In connection with the extension, holders of 2,601,058 Class A Ordinary Shares redeemed their shares for cash at approximately $12.50 per share, for an aggregate of $32.5 million, leaving $5.9 million in the Trust Account.

Rhea-AI Summary

Cartesian Growth Corporation II agreed to a business combination with InoBat AS, valuing InoBat at $1,265,000,000, split between $575,000,000 of upfront consideration and up to $690,000,000 of milestone-based earn-outs. Closing is targeted for the fourth quarter of 2026, subject to shareholder and regulatory approvals.

InoBat will form Dutch holding company InoBat N.V. (“ListCo”), which will acquire InoBat and merge CGC into a ListCo subsidiary; CGC shareholders will receive one ListCo share per CGC share, and existing CGC warrants will become ListCo warrants with the same $11.50 exercise price. Earn-out shares, issued at a deemed $10.20 per share, vest only if Project Kamzik is commissioned by December 31, 2027 and if ListCo EBITDA exceeds €47,000,000 and €87,000,000 in specified fiscal years.

The combination includes $77,500,000 of committed capital from PIPE investors and current shareholders and has no minimum-cash condition. Sponsor concessions include forfeiting private warrants, transferring 800,000 CGC Class A shares to an institutional PIPE investor, and converting $9,200,000 of loans into ListCo preference shares and PIPE warrants. Key closing conditions include effectiveness of a Form F-4, Nasdaq listing of ListCo, antitrust and foreign-investment clearances, completion of the PIPE financing, and delivery of shareholder undertakings covering at least 90% of InoBat’s shares.

Rhea-AI Summary

Cartesian Growth Corporation II is postponing its extraordinary general meeting in lieu of an annual meeting of shareholders from July 27, 2026 to July 30, 2026 at 10:30 a.m., Eastern Time, to be held at Greenberg Traurig’s offices in Miami, Florida.

The agenda includes an Extension Proposal to amend the Amended and Restated Memorandum and Articles of Association so the deadline to consummate an initial business combination moves from August 5, 2026 to August 5, 2027. The deadline for shareholders to exercise redemption rights, or reverse prior redemption requests, is extended to July 28, 2026 at 5:00 p.m., Eastern Time.

Rhea-AI Summary

Cartesian Growth Corporation II issued an unsecured promissory note for $250,000 to its sponsor, CGC II Sponsor LLC. The note bears no interest and is due on the earlier of completing the company’s initial business combination or the start of its winding up.

If a business combination occurs, the sponsor may convert some or all of the principal into Working Capital Warrants at $1.00 per warrant, with terms matching the company’s private placement warrants from its IPO. The note was issued under a private-offering exemption in Section 4(a)(2) of the Securities Act of 1933.

Rhea-AI Summary

Cartesian Growth Corporation II reported shareholder approval of an amendment to extend its deadline to complete an initial business combination from November 5, 2025 to August 5, 2026. The measure passed at an extraordinary general meeting with 8,863,937 votes for and 3,155,321 against.

In connection with the vote, holders redeemed 4,173,618 Class A ordinary shares at approximately $12.27 per share. On the October 10, 2025 record date, 12,999,712 ordinary shares were outstanding, and approximately 92.458% were represented at the meeting.

Rhea-AI Summary

Cartesian Growth Corporation II announced it entered into a non-binding Letter of Framework with PLXSUR Limited outlining terms for a potential business combination. The framework memorializes progress and shared objectives but does not obligate either party to proceed.

The company states there is no guarantee it will enter a definitive agreement with PLXSUR or close a transaction by its termination date, which may be extended. Any transaction would require board and stakeholder approvals for both entities, regulatory approvals, and other customary closing conditions.

The company filed a preliminary proxy statement on October 8, 2025, related to its extraordinary general meeting of shareholders, and urges investors to review it and future definitive materials when available.